Dose-dependent effects of naloxone and methylprednisolone in the ventral compression model of spinal cord injury
- PMID: 2134448
Dose-dependent effects of naloxone and methylprednisolone in the ventral compression model of spinal cord injury
Abstract
A study of the dose-response effects of naloxone and methylprednisolone after rat ventral spinal cord injury is presented. The spinal cord injury model used herein is unique in that it results in a ventral compression of the spinal cord without the need for a prior laminectomy. This allows for a close approximation of the human clinicopathological situation. There was a statistically significant positive effect on neurological outcome with a naloxone dose of 2.5 mg/kg, whereas higher and lower doses yielded little or no influence on outcome. Methylprednisolone was observed to offer similar results. These results, however, did not achieve statistical significance. The early administration of moderately high doses (45-60 mg/kg), however, offered the best results. The responses to the treatment regimens presented here offer hope for spinal cord injury victims. The observed dose-response relationships indicate that erroneous conclusions may arise from studies using inappropriate doses of narcotic antagonists, as well as other drugs.
Similar articles
-
End organ effects of high-dose human equivalent methylprednisolone in a spinal cord injury rat model.Spine (Phila Pa 1976). 2006 Feb 1;31(3):257-61. doi: 10.1097/01.brs.0000197151.95849.7f. Spine (Phila Pa 1976). 2006. PMID: 16449896
-
A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.N Engl J Med. 1990 May 17;322(20):1405-11. doi: 10.1056/NEJM199005173222001. N Engl J Med. 1990. PMID: 2278545 Clinical Trial.
-
Secondary injury mechanisms in acute spinal cord injury.J Emerg Med. 1993;11 Suppl 1:13-22. J Emerg Med. 1993. PMID: 8445198 Review.
-
Treatment of acute spinal cord injury with methylprednisolone: results of a multicenter, randomized clinical trial.J Neurotrauma. 1991 Jul;8 Suppl 1:S47-50; discussion S51-2. J Neurotrauma. 1991. PMID: 1920461 Clinical Trial.
-
High-dose methylprednisolone in the treatment of spinal cord injuries.Heart Lung. 1991 Nov;20(6):675-80. Heart Lung. 1991. PMID: 1960072 Review.
Cited by
-
Mn (III) tetrakis (4-benzoic acid) porphyrin scavenges reactive species, reduces oxidative stress, and improves functional recovery after experimental spinal cord injury in rats: comparison with methylprednisolone.BMC Neurosci. 2013 Mar 1;14:23. doi: 10.1186/1471-2202-14-23. BMC Neurosci. 2013. PMID: 23452429 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical